HealthEquity (NASDAQ:HQY) Cut to Hold at Wall Street Zen

Wall Street Zen downgraded shares of HealthEquity (NASDAQ:HQY) from a buy rating to a hold rating in a research report report published on Saturday morning.

HQY has been the topic of a number of other reports. Weiss Ratings raised shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. BTIG Research lifted their price objective on shares of HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a report on Friday, July 24th. Citizens Jmp lifted their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. Barrington Research reiterated an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a research report on Friday, May 22nd. Finally, KeyCorp reissued an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Eleven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, HealthEquity has an average rating of “Moderate Buy” and an average target price of $110.93.

HealthEquity Stock Up 2.1%

Shares of HQY stock opened at $106.79 on Friday. The stock has a 50 day moving average of $93.69 and a 200 day moving average of $85.95. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The stock has a market cap of $8.93 billion, a P/E ratio of 40.00, a P/E/G ratio of 1.76 and a beta of 0.21. HealthEquity has a twelve month low of $72.76 and a twelve month high of $107.62.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. The business had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, sell-side analysts expect that HealthEquity will post 3.92 EPS for the current year.

Insider Activity

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the transaction, the executive vice president directly owned 59,113 shares in the company, valued at approximately $5,615,735. This represents a 5.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the transaction, the executive vice president directly owned 91,141 shares in the company, valued at approximately $8,202,690. The trade was a 7.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 17,905 shares of company stock worth $1,651,280 in the last quarter. Corporate insiders own 1.60% of the company’s stock.

Institutional Trading of HealthEquity

A number of institutional investors and hedge funds have recently modified their holdings of HQY. Acumen Wealth Advisors LLC acquired a new stake in HealthEquity in the 4th quarter worth about $27,000. Caitong International Asset Management Co. Ltd increased its stake in HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after buying an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of HealthEquity during the fourth quarter valued at approximately $28,000. Leonteq Securities AG raised its holdings in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares during the last quarter. Finally, Axiom Investment Management LLC purchased a new position in shares of HealthEquity in the first quarter valued at approximately $33,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.